Literature DB >> 21443827

Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation.

Dionisios Vrochides1, Mazzen Hassanain, Jeffrey Barkun, Jean Tchervenkov, Steven Paraskevas, Prosanto Chaudhury, Marcelo Cantarovich, Marc Deschenes, Phil Wong, Peter Ghali, Gabriel Chan, Peter Metrakos.   

Abstract

BACKGROUND: The ability of Child-Turcotte-Pugh (CTP) or Model for End-Stage Liver Disease (MELD) scores to predict recipient survival after liver transplantation is controversial. This analysis aims to identify preoperative parameters that might be associated with early postoperative mortality and long-term survival after liver transplantation.
METHODS: We studied a total of 15 parameters, using both univariate and multivariate models, among adults who underwent primary liver transplantation.
RESULTS: A total of 458 primary adult liver transplants were performed. Fifty-seven (12.44%) patients died during the first 3 postoperative months and composed the early mortality group. The remaining 401 patients composed the long-term patient survival group. The parameters that were identified through univariate analysis to be associated with early postoperative mortality were CTP score, MELD score, bilirubin, creatinine, international normalized ratio and warm ischemia time (WIT). In all multivariate models, WIT retained its statistical significance. The 10-year long-term survival was 65%. The parameters that were identified to be independent predictors of long-term survival were the recipient's sex (improved survival in women, p = 0.005), diagnosis of hepatocellular cancer (p=0.015) and recipient's age (p=0.024).
CONCLUSION: Either CTP or MELD score, in conjunction with WIT, might have a role in predicting early postoperative mortality after liver transplantation, whereas the recipient's sex and the absence of hepatocellular cancer are associated with improved long-term survival.
© 2011 Canadian Medical Association

Entities:  

Mesh:

Year:  2011        PMID: 21443827      PMCID: PMC3116707          DOI: 10.1503/cjs.035909

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  20 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

Review 2.  Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?

Authors:  Erik Christensen
Journal:  J Hepatol       Date:  2004-08       Impact factor: 25.083

3.  Evidence-based incorporation of serum sodium concentration into MELD.

Authors:  Scott W Biggins; W Ray Kim; Norah A Terrault; Sammy Saab; Vijay Balan; Thomas Schiano; Joanne Benson; Terry Therneau; Walter Kremers; Russell Wiesner; Patrick Kamath; Goran Klintmalm
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

4.  An analysis of late deaths after liver transplantation.

Authors:  S Asfar; P Metrakos; J Fryer; D Verran; C Ghent; D Grant; M Bloch; P Burns; W Wall
Journal:  Transplantation       Date:  1996-05-15       Impact factor: 4.939

5.  MELD and other factors associated with survival after liver transplantation.

Authors:  K V Narayanan Menon; Scott L Nyberg; William S Harmsen; Nelson F DeSouza; Charles B Rosen; Ruud A F Krom; Russell H Wiesner
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

6.  Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.

Authors:  Niraj M Desai; Kevin C Mange; Michael D Crawford; Peter L Abt; Adam M Frank; Joseph W Markmann; Ergun Velidedeoglu; William C Chapman; James F Markmann
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

7.  Pretransplant MELD score and post liver transplantation survival in the UK and Ireland.

Authors:  Mathew Jacob; Lynn P Copley; James D Lewsey; Alex Gimson; Giles J Toogood; Mohamed Rela; Jan H P van der Meulen
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

8.  Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.

Authors:  Francis Y Yao; Sammy Saab; Nathan M Bass; Ryutaro Hirose; David Ly; Norah Terrault; Ann A Lazar; Peter Bacchetti; Nancy L Ascher; John P Roberts
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

View more
  3 in total

1.  Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients.

Authors:  Thomas Lescot; Constantine J Karvellas; Prosanto Chaudhury; Jean Tchervenkov; Steven Paraskevas; Jeffrey Barkun; Peter Metrakos; Peter Goldberg; Sheldon Magder
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

2.  Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients.

Authors:  Ivan Dias de Campos Junior; Raquel Silveira Bello Stucchi; Elisabete Yoko Udo; Ilka de Fátima Santana Ferreira Boin
Journal:  Hepatol Int       Date:  2014-08-09       Impact factor: 6.047

3.  Outcomes of liver transplant recipients with high MELD scores: an experience from a Canadian centre.

Authors:  Michael S Bleszynski; Subin Punnen; Sameer Desai; Trana Hussaini; Vladimir Marquez; Eric M Yoshida; Saumya Jayakumar; Stephanie Chartier-Plante; Maja Segedi; Charles H Scudamore; Stephen Chung; Andrzej K Buczkowski; Peter T W Kim
Journal:  Can J Surg       Date:  2022-07-05       Impact factor: 2.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.